Proteome Sciences plc (LON:PRM – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.78 ($0.04), with a volume of 455149 shares changing hands. The stock had previously closed at GBX 2.60 ($0.03).
Proteome Sciences Stock Up 6.7 %
The firm has a market cap of £8.19 million, a P/E ratio of -277.50 and a beta of 0.07. The firm has a fifty day moving average of GBX 2.84 and a 200-day moving average of GBX 3.32.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- Upcoming IPO Stock Lockup Period, Explained
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Quiet Period Expirations Explained
- Williams-Sonoma Stock: Buy It and Never Let It Go
- NYSE Stocks Give Investors a Variety of Quality Options
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
